NCAM1 and COVID-19: When directly comparing LPS-stimulated classical monocytes from convalescent COVID-19 patients to those from uninfected subjects, there was a statistically significant increase in the percentage of cells expressing bright CD4 and CD69, a significant decrease in the percentage of cells expressing CD56, and no difference in the percentage of cells expressing CD83 or CD86.